XORTX Therapeutics (XRTX) Exchange Rate Effect (2021 - 2026)
XORTX Therapeutics' (XRTX) quarterly Exchange Rate Effect came in at -$763.0 in Q1 2026, down 167.7% YoY from $1127.0 in Q1 2025, and down 118.25% on a QoQ basis from $4181.0 in Q4 2025.
XORTX Therapeutics (XRTX) Exchange Rate Effect (2021 - 2026) Analysis & Trends
XORTX Therapeutics (XRTX) has 6 years of Exchange Rate Effect data on file, last reported at -$763.0 in Q1 2026.
- Quarterly Exchange Rate Effect fell 167.7% year-over-year to -$763.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $25107.0 (up 198.42% YoY) and the FY2025 annual result came in at $26997.0, up 175.09% from the prior year.
- Exchange Rate Effect eased to -$763.0 in Q1 2026, from $4181.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $477968.9 in Q3 2022 to a low of -$133194.8 in Q1 2022.
- A 5-year average of $38990.6 and a median of $1127.0 in 2025 frame the typical range for Exchange Rate Effect.
- The widest YoY moves for Exchange Rate Effect: up 8045.12% in 2024, down 2906.95% in 2024.
- Tracing XRTX's Exchange Rate Effect over 5 years: stood at $51141.9 in 2022, then slumped by 102.84% to -$1453.0 in 2023, then sank by 2906.95% to -$43691.0 in 2024, then jumped by 109.57% to $4181.0 in 2025, then sank by 118.25% to -$763.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$763.0 (Q1 2026), $4181.0 (Q4 2025), and -$5338.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -2.45 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -287,000.00 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.63 Mn |
| 10 | XORTX Therapeutics | 2.78 Mn | 2.78 Mn | - | -763.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -763.00 |
| Mar 31, 2026 | -763.00 |
| Dec 31, 2025 | 4,181.00 |
| Dec 31, 2025 | 4,181.00 |
| Sep 30, 2025 | -5,338.00 |
| Sep 30, 2025 | -5,338.00 |
| Jun 30, 2025 | 27,027.00 |
| Jun 30, 2025 | 27,027.00 |
| Mar 31, 2025 | 1,127.00 |
| Mar 31, 2025 | 1,127.00 |
| Dec 31, 2024 | -43,691.00 |
| Dec 31, 2024 | -43,691.00 |
| Sep 30, 2024 | 19,545.00 |
| Sep 30, 2024 | 19,545.00 |
| Jun 30, 2024 | -2,490.00 |
| Jun 30, 2024 | -2,490.00 |
| Mar 31, 2024 | -9,317.00 |
| Mar 31, 2024 | -9,317.00 |
| Dec 31, 2023 | -1,453.00 |
| Dec 31, 2023 | -1,453.00 |